Pfister Alfred K, Welch Christine A, John Molly, Emmett Mary K
From the Department of Medicine, West Virginia School of Medicine, Charleston, and the Department of Health Services and Outcomes Research, Charleston Area Medical Center Health Education and Research Institute, Charleston, West Virginia.
South Med J. 2016 Feb;109(2):118-23. doi: 10.14423/SMJ.0000000000000410.
Osteopenia is considerably more common than osteoporosis and accounts for most of the fracture burden in women older than 50 years. It is uncertain when to initiate treatment in osteopenia. We sought to determine in women with osteopenia what effect transitioning to lower categories had on subsequent fracturing.
We surveyed 1150 women from office-based practices who had initial normal or osteopenic bone mineral densities (BMDs) and who were retested after 5.75 years. We classified categories related to baseline T scores as follows: normal (>-1.0), mild osteopenia (-1.0 to -1.49), moderate osteopenia (-1.5 to -1.99), and severe osteopenia (-2.0 to -2.49). We determined during a 9.6-year follow-up period the fracture occurrence in those who maintained their initial category status or transitioned into lower categories.
Transitioning to lower categories was not significantly different among baseline osteopenic categories but significantly more than normal baseline BMDs. Total fractures, individuals fracturing, and major fractures were significantly more, with baseline T scores of ≤-1.5 (<0.001). Although only 10.2% transitioned to osteoporosis, 90.5% of these transitions occurred with baseline T scores ≤-1.5 and accounted for significantly more fractures than baseline T scores of >-1.5.
Most subsequent fractures and transitions to osteoporosis occurred with baseline T scores ≤-1.5. Clinical risk factors need to be used to determine at what T score threshold treatment would be cost effective.
骨质减少比骨质疏松更为常见,并且在50岁以上女性的骨折负担中占大部分。骨质减少何时开始治疗尚不确定。我们试图确定骨质减少的女性向更低类别转变对随后骨折有何影响。
我们调查了1150名来自门诊的女性,她们最初的骨矿物质密度(BMD)正常或为骨质减少,并在5.75年后重新进行了检测。我们将与基线T值相关的类别分类如下:正常(>-1.0)、轻度骨质减少(-1.0至-1.49)、中度骨质减少(-1.5至-1.99)和重度骨质减少(-2.0至-2.49)。我们在9.6年的随访期内确定了那些维持其初始类别状态或转变为更低类别的人的骨折发生情况。
在基线骨质减少类别中,向更低类别转变没有显著差异,但显著多于正常基线BMD。总骨折、骨折个体和主要骨折在基线T值≤-1.5时显著更多(<0.001)。虽然只有10.2%转变为骨质疏松,但这些转变中有90.5%发生在基线T值≤-1.5时,并且比基线T值>-1.5时导致的骨折显著更多。
大多数随后的骨折和向骨质疏松的转变发生在基线T值≤-1.5时。需要使用临床风险因素来确定在什么T值阈值下治疗具有成本效益。